97 related articles for article (PubMed ID: 9013837)
1. Pleural mesotheliomas have an integrin profile distinct from visceral carcinomas.
Koukoulis GK; Shen J; Monson R; Warren WH; Virtanen I; Gould VE
Hum Pathol; 1997 Jan; 28(1):84-90. PubMed ID: 9013837
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of integrins in the normal lung and in pulmonary carcinomas.
Koukoulis GK; Warren WH; Virtanen I; Gould VE
Hum Pathol; 1997 Sep; 28(9):1018-25. PubMed ID: 9308725
[TBL] [Abstract][Full Text] [Related]
3. The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas.
Peralta Soler A; Knudsen KA; Jaurand MC; Johnson KR; Wheelock MJ; Klein-Szanto AJ; Salazar H
Hum Pathol; 1995 Dec; 26(12):1363-9. PubMed ID: 8522310
[TBL] [Abstract][Full Text] [Related]
4. Basal lamina reduplication in malignant epithelioid pleural mesothelioma.
Di Muzio M; Spoletini L; Strizzi L; Procopio A; Tassi G; Casalini A; Modesti A
Ultrastruct Pathol; 1998; 22(6):467-75. PubMed ID: 9891926
[TBL] [Abstract][Full Text] [Related]
5. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura.
Soini Y; Kinnula V; Kahlos K; Pääkkö P
J Clin Pathol; 2006 Mar; 59(3):250-4. PubMed ID: 16505274
[TBL] [Abstract][Full Text] [Related]
6. Integrin laminin receptor profile of pulmonary squamous cell and adenocarcinomas.
Patriarca C; Alfano RM; Sonnenberg A; Graziani D; Cassani B; de Melker A; Colombo P; Languino LR; Fornaro M; Warren WH; Coggi G; Gould VE
Hum Pathol; 1998 Nov; 29(11):1208-15. PubMed ID: 9824097
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical differentiation of sarcomatoid mesotheliomas from other spindle cell neoplasms.
Cagle PT; Truong LD; Roggli VL; Greenberg SD
Am J Clin Pathol; 1989 Nov; 92(5):566-71. PubMed ID: 2479255
[TBL] [Abstract][Full Text] [Related]
8. Identification of receptors binding fibronectin and laminin on fetal rat lung cells.
Caniggia I; Liu J; Han R; Wang J; Tanswell AK; Laurie G; Post M
Am J Physiol; 1996 Mar; 270(3 Pt 1):L459-68. PubMed ID: 8638739
[TBL] [Abstract][Full Text] [Related]
9. Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma.
Ordóñez NG
Mod Pathol; 1998 Oct; 11(10):929-33. PubMed ID: 9796717
[TBL] [Abstract][Full Text] [Related]
10. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
[TBL] [Abstract][Full Text] [Related]
11. Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of beta1 integrins.
Klominek J; Sumitran Karuppan S; Hauzenberger D
Int J Cancer; 1997 Sep; 72(6):1034-44. PubMed ID: 9378538
[TBL] [Abstract][Full Text] [Related]
12. Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma.
Soini Y; Kahlos K; Puhakka A; Lakari E; Säily M; Pääkkö P; Kinnula V
Br J Cancer; 2000 Oct; 83(7):880-6. PubMed ID: 10970689
[TBL] [Abstract][Full Text] [Related]
13. Desmin and neural marker expression in mesothelial cells and mesotheliomas.
Hurlimann J
Hum Pathol; 1994 Aug; 25(8):753-7. PubMed ID: 7520015
[TBL] [Abstract][Full Text] [Related]
14. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
Ordóñez NG
Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
[TBL] [Abstract][Full Text] [Related]
15. Malignant mesothelioma: cytologic diagnosis with histologic, immunohistochemical, and ultrastructural correlation.
Leong AS; Stevens MW; Mukherjee TM
Semin Diagn Pathol; 1992 May; 9(2):141-50. PubMed ID: 1609156
[TBL] [Abstract][Full Text] [Related]
16. [Surfactant protein and thyroid transcription factor 1 in pleuro-pulmonary neoplasia. Immunohistochemical study].
Dessy E; Falleni M; Del Curto B; Braidotti P; Pietra GG
Pathologica; 2000 Dec; 92(6):496-502. PubMed ID: 11234300
[TBL] [Abstract][Full Text] [Related]
17. Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.
Sheibani K; Battifora H; Burke JS
Am J Pathol; 1986 May; 123(2):212-9. PubMed ID: 2422942
[TBL] [Abstract][Full Text] [Related]
18. Modulation of integrin expression on mesotheliomas: the role of different histotypes in invasiveness.
Giuffrida A; Vianale G; Di Muzio M; Pass HI; Coletti A; Birarelli P; Procopio A; Modesti A
Int J Oncol; 1999 Sep; 15(3):437-42. PubMed ID: 10427122
[TBL] [Abstract][Full Text] [Related]
19. CD31 immunoreactivity in carcinomas and mesotheliomas.
De Young BR; Frierson HF; Ly MN; Smith D; Swanson PE
Am J Clin Pathol; 1998 Sep; 110(3):374-7. PubMed ID: 9728613
[TBL] [Abstract][Full Text] [Related]
20. Mucin-positive epithelial mesothelioma.
MacDougall DB; Wang SE; Zidar BL
Arch Pathol Lab Med; 1992 Aug; 116(8):874-80. PubMed ID: 1341882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
